RESLIZUMAB

UNII:	35A26E427H
Type:	INGREDIENT SUBSTANCE
Formula:
Preferred Substance Name:	RESLIZUMAB
GSRS Full Record:	35A26E427H i

241473-69-8
CEP-38072
CINQAIR
DCP 835
DCP-835
Immunoglobulin G4, anti-(human interleukin 5) (human-rat monoclonal SCH 55700 γ4-chain), disulfide with human-rat monoclonal SCH 55700 light chain, dimer
MAB HUMAN (IGG4) ANTI P05113 (IL5_HUMAN) (SCH55700)
RESLIZUMAB [MI]
RESLIZUMAB [PURPLE BOOK CDER]
RESLIZUMAB [USAN]
Reslizumab [WHO-DD]
SCH-55700
SCH55700
reslizumab [INN]

Common Chemistry
i
Inxight Drugs
i
DailyMed Regulated Products
i
NCI Thesaurus
i

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

RESLIZUMAB

Synonyms and Mappings

Resources